Neurostimulation Devices Market Scope And Analysis

  • Report Code : TIPRE00002778
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 172
Buy Now

Neurostimulation Devices Market Analysis and Scope (2023 to 2030)

Buy Now


Neurostimulation Devices Market Report Scope

Report Attribute Details
Market size in 2022 US$ 5.8 Billion
Market Size by 2030 US$ 11.83 Billion
Global CAGR (2022 - 2030) 9.3%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Product
  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
By Application
  • Pain Management
  • Epilepsy
  • Urinary and Fecal Incontinence
  • Parkinson's Disease
By End User
  • Hospitals
  • Specialty Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
  • Nevro Corp
  • LivaNova Plc
  • Synapse Biomedical Inc
  • Nalu Medical Inc
  • ElectroCore Inc
  • MicroTransponder Inc
  • Company Profiles

    • Medtronic Plc
    • Boston Scientific Corp
    • Abbott Laboratories
    • Nevro Corp
    • LivaNova Plc
    • Synapse Biomedical Inc
    • Nalu Medical, Inc
    • ElectroCore Inc
    • MicroTransponder Inc
    • Mainstay Medical